Identification of a furazolidone metabolite responsible for the inhibition of amino oxidases

References

• ABELL, C. W. and KWAN, S. W., 2000, Molecular characterization of monoamine oxidases A and B. Progress in Nucleic Acid Research and Molecular Biology, 65, 129–156.
   Google Scholar
• ALI, B. H., 1999, Pharmacological, therapeutic and toxicological properties of furazolidone: some recent research. Veterinary Research Communications, 23, 343–360.
   PubMed Web of Science ®Google Scholar
• ALI, B. H. and BARTLET, A. L., 1982, Inhibition of monoamine oxidase in chickens and ducklings by a microbial metabolite of furazolidone. Quarterly Journal of Experimental Physiology, 67, 69–79.
   PubMed Web of Science ®Google Scholar
• BELLEAU, B., 1965, Conformational perturbation in relation to the regulation of enzyme and receptor behaviour [Review]. Advances in Drug Research, 2, 89–126.
   PubMedGoogle Scholar
• BROWN, D. M., UPCROFT, J. A. and UPCROFT, P., 1996, A H20-producing NADH oxidase from the protozoan parasite Giardia duodenalis. European Journal of Biochemistry, 241, 155–161.
   PubMedGoogle Scholar
• CALLA, D. R., 1983, Mutagenicity of nitrofuran derivatives: review. Environmental Mutagenisis, 5, 745–765.
   PubMedGoogle Scholar
• GARDNER, T. B. and HILL, T. B., 2001, Treatment of giardiasis. Clinical and Microbiology Reviews, 14, 114–128.
   PubMed Web of Science ®Google Scholar
• GRAHAM, D. Y., OSATO, M. S., HOFFMAN, J. and ELZIMAITY, H. M., 1994, Furazolidone combination therapies for Helicobacter pylori infection in the United States. Alimentary and Pharmacology Therapy, 14, 211–215.
   Google Scholar
• GRAHAM, D. Y. and QURESCI, W. A., 2000, Antibiotic-resistant H. pylori infection and its treatment. Current Pharmaceutical Design, 6, 1537–1544.
   PubMed Web of Science ®Google Scholar
• GUTIRREZ, M. C., GOMEZ-HENS, A. and PEREZ-BENDITO, D., 1989, Spectrophotometric determination of hydrazine and phenylhydrazine by dimethylaminobenzaldehyde. Analitica et Chimica Acta, 225, 115–122.
   Google Scholar
• HOOGENBOOM, L. A., BERGHMANS, M. C., PALMAN, T. H., PARKER, R. and SHAW, I. C., 1992, Depletion of protein-bound furazolidone metabolites containing the 3-amino-2-oxazolidinone side-chain rom liver, kidney and muscle tissues of pigs. Food Additives and Contaminants, 9, 623–630.
   PubMed Web of Science ®Google Scholar
• HOOGENBOOM, L. A., POLAM, T. H., LOMMEN, A., HUVENEERS, M. B. and VAN RHUN, J., 1994, Biotransformation of furaltadone by pig hepatocytes and Salmonella typhimurium T A 100 bacteria, and the formation of protein-bound metabolites. Xenobiotica, 24, 713–727.
   PubMed Web of Science ®Google Scholar
• HOOGENBOOM, L. A., TOMASSINI, O., OORSPRONG, M. B. and KUIPER, H. A., 1991b, Use of pig hepatocites to study the inhibition of monoamine oxidase by furazolidone. Food and Chemical Toxicology, 29, 185–191.
   PubMed Web of Science ®Google Scholar
• HOOGENBOOM, L. A., VAN KAMMEN, M., BERGHMANS, M. C. and KUIPER, H. A., 1991a, The USC Of pig hepatocytes to study the nature of protein-bound metabolites of furazolidone, a new analytical method for their detection. Food and Chemical Toxicology, 29, 321–328.
   PubMed Web of Science ®Google Scholar
• HORNE, E., CADOGAN, A., O.KEEFFE, M. and HOOGENBOOM, L. A., 1996, Analysis of protein-bound metabolites of furazolidone and furaltadone in pig liver by high-performance liquid chromatography and liquid chromatography-mass spectrometry. Analyst, 121, 1463–1468.
   Google Scholar
• JANES, S. M., MU, D., WEMMER, D., SMITH, A. J., KAUR, S., MALTBY, D., BURLINGAME, A. L. and KL INMAN, J. P., 1990, A new redox cofactor in eukariotic enzymes, 6-hydroxy-dopa at the active site of bovine serum amino oxidase. Science, 248, 981–987.
   PubMed Web of Science ®Google Scholar
• KLEE, S BAUMUNG, I., KLUGE, K., UNGEMACH, F. R., HORNE, E., O.KEEFFE, M., DE ANGELIS, I., Zucco. F. and S TAMMAT I, A., 1999, A contribution to safety assessment of veterinary drug residues, in vitro intestinal toxicity and transport of covalently bound residues. Xenobiotica, 29, 641–654.
   Google Scholar
• KOBIRSKA-SZELIGA, M. and CZECZOT H., 1994, Characterization of the genotoxic properties of nitrofurans nitrofurazone and furazolidone: review. Acta Biochemica Polonica, 41, 1–5.
   PubMedGoogle Scholar
• KUMAR, L., TOOTHILL, J. R. and Ho, K. B., 1994, Determination of nitrofuran residues in poultry muscle tissues and eggs by liquid chromatography. Journal of AOAC International, 77, 591–595.
   PubMed Web of Science ®Google Scholar
• LAx, D. and KuKoLicil, S. G., 1992, Generation of furazolidone radical anion and its inhibition by glutathione. Biochemical Medicine and Metabolic Biology, 48, 56–63.
   PubMedGoogle Scholar
• LAX, D., MARTINEZ- ZAGUILAN, R. and GILL IES, R. J., 1994, Furazolidone increases thapsigargin sensitive Ca(2 + )-ATPase in chick cardiac myocytes. American Journal of Physiology, 267, 734–741.
   Google Scholar
• LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin-phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• Lu, A. Y. H., MIWA, G. T. and WisLocKi, P. G., 1998, Toxicological significance of covalently bound drug residues. Reviews in Biochemical Toxicology, 9, 1–27.
   Google Scholar
• MORINAN, A. and GARRATT, H. M., 1985, An improved fiuorimetric assay for brain monoamine oxidase. Journal of Pharmacological Methods, 13, 213–223.
   PubMedGoogle Scholar
• PATEL, N. T., FRITZ, R. R. and ABELL, C. W., 1984, Isolation of pure, catalytically active human liver monoamine oxidase B: antibody complex. Biochemical and Biophysical Research Communications, 125, 748–754.
   PubMed Web of Science ®Google Scholar
• PINTO, M. S., ROB INE-LEON, M. D., APPAY, M., KEDINGER, N., TRIADOU, E., DUSSAULX, B., LACROIX, P., S IMON-ASSMANN, K., HAFFEN, J., FOGH, D. and ZWEIBAUM, A., 1983, Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biologie Cellulaire, 47, 323–330.
   Google Scholar
• RACIT I, G., MAZ ZONE, P., RAUDINO, A., MAZ ZONE, G. and CAMBRI A., 1995, Inhibition of rat liver mitochondrial oxidase by hydrazine-thiazole derivatives: structure—activity relationships. Bioorganic and Medicinal Chemistry, 3, 1485–1491.
   PubMed Web of Science ®Google Scholar
• Rossi, L., DE ANGELIS, I., PEDERSEN, J. Z., MARCHESE, E., STAMMAT I, A., ROT IL IO, G. and Zucco, F., 1996, [5-Nitro-2-furfurylidene]-3-amino-2-oxazolidinone activation by the human intestinal cell line Caco-2 monitored through noninvasive electron spin resonance spectroscopy. Molecular Pharmacology, 49, 547–555.
   PubMed Web of Science ®Google Scholar
• Rupp, H. S., MUNNS, R. K., LONG, A. R. and PLAKAS, S. M., 1994, Simultaneous determination of nitrofurazone, nitrofurantoin, and furazolidone in channel catfish (Ictalurus punctatus) muscle tissue by liquid chromatography. Journal of AOAC International, 77, 344–350.
   PubMed Web of Science ®Google Scholar
• SAS, B., 1993, Contribution to the pathobiochemistry of furazolidone-induced oxidative toxicity in chickens. Acta Veterinaria Hungarica, 41, 103–121.
   PubMed Web of Science ®Google Scholar
• SROL IN- BENEDETT I, M. and TIPTON, K. F., 1998, Monoamine oxidases and related amine oxidases as phase I enzymes in the metabolism of xenobiotics [Review]. Journal of Neural Transmitters Supplement, 52, 149–171.
   Google Scholar
• STAMMATI, A., TRUCCHI, D., ZAMPAGLIONI, F., MACRI, A. and Zucco, F., 1988, Cytotoxic effects of furazolidone on two cell lines. Toxicology In Vitro, 2, 279–286.
   Google Scholar
• STERN, I. V., HOLLIELD, R. D., WILK, S. and BUZARD, J. A., 1967, The anti-monoamine oxidase effects of furazolidone. Journal of Pharmacology and Experimental Therapeutics, 156, 492–499.
   PubMed Web of Science ®Google Scholar
• SUZUKI, S., SAKURAI, T., NAKAHARA. A., MANABE, T. and OKUYAMA, T., 1983, Effect of metal substitution on the chromophore of bovine serum amine oxidase. Biochemistry, 22, 1630–1635.
   Google Scholar
• TABOR, C. W., TABOR, H. and ROSENTHAL, S. M., 1954, Purification of amino oxidase from beef plasma. Journal of Biological Chemistry, 208, 645–661.
   PubMed Web of Science ®Google Scholar
• TIPTON, K. F., 1994, Monoamine oxidase inhibition [Review]. Biochemical Society Transactions, 22, 764–768.
   PubMed Web of Science ®Google Scholar
• TOTH, B., 2000, A review of the natural occurrence, synthetic production and use of carcinogenic hydrazines and related chemicals [Review]. In Vivo, 14, 299–319.
   PubMed Web of Science ®Google Scholar
• TURINI, P., SABATINI, S BEFANI, O., CIMENT I, F., CASANOVA, C., RICCIO, P. and MONDOVI, B., 1982, Purification of bovine plasma amine oxidase. Annals of Biochemistry, 125, 294–298.
   Google Scholar
• VROOMEN, L. H. M BERGHMANS, M. C. J., GROTEN, J. P., KOEMAN, J. H. and BLADEREN, P. J., 1988, Reversible interaction of a reactive intermediate derived from furazolidone with glutathione and protein. Toxicology and Applied Pharmacology, 95, 53–60.
   Google Scholar
• VROOMEN, L. H. M., BERGHMANS, M. C. J., LEEUWEN, P., VAN STRUHS, T. D. B., VAN VRIES, P. H. U. and KUIPER, H. A., 1986, Kinetics of 4C-furazolidone in pig lets upon oral administration during 10 days and its interaction with tissue macro-molecules. Food Additives and Contaminants, 3, 331–346.
   Google Scholar
• YATSIMIRSKY, A. K., KRIVOVA, S. B. AND YATSIMIRSKAYA, N. T., 1992, Effect of sodium-dodecyl-sulfate on determination of phenylhydrazine. Zhurnal Obshchei Biologii., 62, 916-922; trans. Journal of General Chemistry, 62, 752–757.
   Google Scholar